|
US46016A
(en)
*
|
|
1865-01-24 |
|
Improvement in coats with inner sleeves |
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
US4874237A
(en)
|
1987-05-07 |
1989-10-17 |
Lions Eye Inst. Of Western Australia |
Electroretinogram apparatus
|
|
CA2002839C
(en)
|
1988-11-14 |
2000-10-10 |
Neal S. Young |
Parvovirus capsids
|
|
FR2643252B1
(fr)
|
1989-02-21 |
1991-06-07 |
Technomed Int Sa |
Appareil de destruction selective de cellules incluant les tissus mous et les os a l'interieur du corps d'un etre vivant par implosion de bulles de gaz
|
|
US5112946A
(en)
|
1989-07-06 |
1992-05-12 |
Repligen Corporation |
Modified pf4 compositions and methods of use
|
|
US5436146A
(en)
|
1989-09-07 |
1995-07-25 |
The Trustees Of Princeton University |
Helper-free stocks of recombinant adeno-associated virus vectors
|
|
US6379885B1
(en)
|
1989-09-14 |
2002-04-30 |
Rijksuniversiteit Te Leiden |
Human parvovirus B19 proteins and virus-like particles, their production and their use in diagnostic assays and vaccines
|
|
WO1992008796A1
(en)
|
1990-11-13 |
1992-05-29 |
Immunex Corporation |
Bifunctional selectable fusion genes
|
|
US5383917A
(en)
|
1991-07-05 |
1995-01-24 |
Jawahar M. Desai |
Device and method for multi-phase radio-frequency ablation
|
|
GB9206016D0
(en)
|
1992-03-19 |
1992-04-29 |
Sandoz Ltd |
Improvements in or relating to organic compounds
|
|
WO1994021679A1
(en)
|
1993-03-25 |
1994-09-29 |
Merck & Co., Inc. |
Inhibitor of vascular endothelial cell growth factor
|
|
AU6953394A
(en)
|
1993-05-21 |
1994-12-20 |
Targeted Genetics Corporation |
Bifunctional selectable fusion genes based on the cytosine deaminase (cd) gene
|
|
US5814618A
(en)
|
1993-06-14 |
1998-09-29 |
Basf Aktiengesellschaft |
Methods for regulating gene expression
|
|
EP0745134A1
(en)
|
1994-02-22 |
1996-12-04 |
Danafarber Cancer Institute |
Nucleic acid delivery system, method of synthesis and uses thereof
|
|
US6551618B2
(en)
|
1994-03-15 |
2003-04-22 |
University Of Birmingham |
Compositions and methods for delivery of agents for neuronal regeneration and survival
|
|
FR2718150B1
(fr)
|
1994-03-29 |
1996-04-26 |
Rhone Poulenc Rorer Sa |
Virus recombinants, préparation et utilisation en thérapie génique.
|
|
US5639725A
(en)
|
1994-04-26 |
1997-06-17 |
Children's Hospital Medical Center Corp. |
Angiostatin protein
|
|
US5527533A
(en)
|
1994-10-27 |
1996-06-18 |
Board Of Trustees Of The University Of Illinois |
Method of retarding and ameliorating central nervous system and eye damage
|
|
US20020168342A1
(en)
|
1994-11-03 |
2002-11-14 |
Cell Genesys, Inc. |
Novel adenoviral vectors, packaging cell lines, recombinant adenoviruses and methods
|
|
US6440425B1
(en)
|
1995-05-01 |
2002-08-27 |
Aventis Pasteur Limited |
High molecular weight major outer membrane protein of moraxella
|
|
US6093570A
(en)
|
1995-06-07 |
2000-07-25 |
The University Of North Carolina At Chapel Hill |
Helper virus-free AAV production
|
|
US6040183A
(en)
|
1995-06-07 |
2000-03-21 |
University Of North Carloina At Chapel Hill |
Helper virus-free AAV production
|
|
US6001650A
(en)
|
1995-08-03 |
1999-12-14 |
Avigen, Inc. |
High-efficiency wild-type-free AAV helper functions
|
|
US6013516A
(en)
|
1995-10-06 |
2000-01-11 |
The Salk Institute For Biological Studies |
Vector and method of use for nucleic acid delivery to non-dividing cells
|
|
US5641749A
(en)
|
1995-11-29 |
1997-06-24 |
Amgen Inc. |
Method for treating retinal ganglion cell injury using glial cell line-derived neurothrophic factor (GDNF) protein product
|
|
US6096548A
(en)
|
1996-03-25 |
2000-08-01 |
Maxygen, Inc. |
Method for directing evolution of a virus
|
|
AU2678097A
(en)
|
1996-04-16 |
1997-11-07 |
Immusol Incorporated |
Targeted viral vectors
|
|
CA2260992C
(en)
|
1996-08-20 |
2004-03-09 |
The Regents Of The University Of California |
Eye treatments using synthetic thyroid hormone compositions
|
|
ATE343400T1
(de)
|
1996-09-24 |
2006-11-15 |
Merck & Co Inc |
Verbindungen zur hemmung der angiogenese durch gentherapie
|
|
FR2756297B1
(fr)
|
1996-11-22 |
1999-01-08 |
Centre Nat Rech Scient |
Procede de production de virus recombinants
|
|
US6153436A
(en)
|
1997-01-10 |
2000-11-28 |
The Board Of Trustees Of The University Of Arkansas |
Method of gene delivery using wildtype adeno associated viral (AAV) vectors with insertions
|
|
AU728220B2
(en)
|
1997-04-14 |
2001-01-04 |
Cell Genesys, Inc. |
Methods for increasing the efficiency of recombinant AAV product
|
|
WO1998051323A1
(en)
|
1997-05-13 |
1998-11-19 |
The Regents Of The University Of California |
Novel antiangiogenic peptide agents and their therapeutic and diagnostic use
|
|
US6710036B2
(en)
|
1997-07-25 |
2004-03-23 |
Avigen, Inc. |
Induction of immune response to antigens expressed by recombinant adeno-associated virus
|
|
US6458157B1
(en)
|
1997-08-04 |
2002-10-01 |
Suaning Gregg Joergen |
Retinal stimulator
|
|
CA2303768C
(en)
|
1997-09-19 |
2009-11-24 |
The Trustees Of The University Of Pennsylvania |
Methods and vector constructs useful for production of recombinant aav
|
|
JPH11100327A
(ja)
|
1997-09-26 |
1999-04-13 |
Toray Ind Inc |
網膜変性症治療剤
|
|
EP1019515A1
(en)
|
1997-10-01 |
2000-07-19 |
G.D. SEARLE & CO. |
Fusion proteins comprising an angiostatin moiety and their use in anti-tumour treatment
|
|
EP1030861A4
(en)
|
1997-10-31 |
2001-09-05 |
Maxygen Inc |
MODIFICATION OF VIRUSTROPISMIUS AND THE ECONOMIC SPECTRUM BY VIRAL GENOM MIXING
|
|
US5994136A
(en)
|
1997-12-12 |
1999-11-30 |
Cell Genesys, Inc. |
Method and means for producing high titer, safe, recombinant lentivirus vectors
|
|
US6410300B1
(en)
|
1998-01-12 |
2002-06-25 |
The University Of North Carolina At Chapel Hill |
Methods and formulations for mediating adeno-associated virus (AAV) attachment and infection and methods for purifying AAV
|
|
CA2318575A1
(en)
|
1998-01-16 |
1999-07-22 |
Chiron Corporation |
Feline immunodeficiency virus gene therapy vectors
|
|
US6551795B1
(en)
|
1998-02-18 |
2003-04-22 |
Genome Therapeutics Corporation |
Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics
|
|
WO1999045952A2
(en)
|
1998-03-12 |
1999-09-16 |
Genentech, Inc. |
Method of preventing the death of retinal neurons and treating ocular diseases
|
|
DE19827457C1
(de)
|
1998-06-19 |
2000-03-02 |
Medigene Ag |
Strukturprotein von AAV, seine Herstellung und Verwendung
|
|
US6593133B1
(en)
|
1998-07-06 |
2003-07-15 |
Nsgene A/S |
Neurotrophic factors
|
|
CA2340276A1
(en)
|
1998-08-28 |
2000-03-09 |
Duke University |
Adenoviruses deleted in the iva2, 100k and/or preterminal protein sequences
|
|
JP2002525064A
(ja)
|
1998-09-11 |
2002-08-13 |
ザ レジェンツ オブ ザ ユニヴァースティ オブ カリフォルニア |
心臓で組織特異的に発現する新規組換えアデノウイルス
|
|
NZ511037A
(en)
|
1998-09-17 |
2005-02-25 |
Univ Florida |
Methods for treatment of degenerative retinal diseases
|
|
US20040234505A1
(en)
|
1998-09-23 |
2004-11-25 |
Stuart Naylor |
Polynucleotide constructs and uses thereof
|
|
ATE454445T1
(de)
|
1998-11-10 |
2010-01-15 |
Univ North Carolina |
Virusvektoren und verfahren für ihre herstellung und verabreichung.
|
|
US6943153B1
(en)
|
1999-03-15 |
2005-09-13 |
The Regents Of The University Of California |
Use of recombinant gene delivery vectors for treating or preventing diseases of the eye
|
|
WO2000054813A2
(en)
|
1999-03-15 |
2000-09-21 |
Chiron Corporation |
Use of recombinant gene delivery vectors for treating or preventing diseases of the eye
|
|
US6498244B1
(en)
|
1999-05-28 |
2002-12-24 |
Cell Genesys, Inc. |
Adeno-associated virus capsid immunologic determinants
|
|
US7070959B1
(en)
|
1999-06-08 |
2006-07-04 |
Regeneron Pharmaceuticals, Inc. |
Modified chimeric polypeptides with improved pharmacokinetic properties
|
|
US7306799B2
(en)
|
1999-06-08 |
2007-12-11 |
Regeneron Pharmaceuticals, Inc. |
Use of VEGF inhibitors for treatment of eye disorders
|
|
US7087411B2
(en)
|
1999-06-08 |
2006-08-08 |
Regeneron Pharmaceuticals, Inc. |
Fusion protein capable of binding VEGF
|
|
US7314912B1
(en)
|
1999-06-21 |
2008-01-01 |
Medigene Aktiengesellschaft |
AAv scleroprotein, production and use thereof
|
|
DE19933288A1
(de)
|
1999-07-15 |
2001-01-18 |
Medigene Ag |
Strukturprotein von Adeno-assoziiertem Virus mit veränderter Antigenität, seine Herstellung und Verwendung
|
|
DE19933719A1
(de)
|
1999-07-19 |
2001-01-25 |
Medigene Ag |
Strukturprotein in Adeno-assoziiertem Virus mit veränderten chromatographischen Eigenschaften, seine Herstellung und Verwendung
|
|
US8232081B2
(en)
|
1999-09-21 |
2012-07-31 |
Basf Se |
Methods and microorganisms for production of panto-compounds
|
|
EP1229839A4
(en)
|
1999-10-25 |
2005-12-07 |
Therus Corp |
USING FOCUSED ULTRASOUND FOR VASCULAR SEALING
|
|
US20070026394A1
(en)
|
2000-02-11 |
2007-02-01 |
Lawrence Blatt |
Modulation of gene expression associated with inflammation proliferation and neurite outgrowth using nucleic acid based technologies
|
|
US6855314B1
(en)
|
2000-03-22 |
2005-02-15 |
The United States Of America As Represented By The Department Of Health And Human Services |
AAV5 vector for transducing brain cells and lung cells
|
|
NZ521952A
(en)
|
2000-04-17 |
2004-03-26 |
Stuart Graham |
Method and apparatus for electrophysiological assessment of visual function using a head-mounted stereo display
|
|
US6329181B1
(en)
|
2000-08-07 |
2001-12-11 |
Neurologix, Inc. |
Helper functions for recombinant vector production
|
|
US7749492B2
(en)
|
2001-01-05 |
2010-07-06 |
Nationwide Children's Hospital, Inc. |
AAV vectors and methods
|
|
WO2002053703A2
(en)
|
2001-01-05 |
2002-07-11 |
Children's Hospital, Inc. |
Aav2 vectors and methods
|
|
US8034803B2
(en)
|
2001-02-06 |
2011-10-11 |
Qlt Inc. |
Photodynamic therapy of occult age-related macular degeneration
|
|
US20040102765A1
(en)
|
2001-03-27 |
2004-05-27 |
Karsten Koenig |
Method for the minimal-to non-invase optical treatment of tissues of the eye and for diagnosis thereof and device for carrying out said method
|
|
WO2002082904A2
(en)
*
|
2001-04-13 |
2002-10-24 |
The Trustees Of The University Of Pennsylvania |
Method of treating or retarding the development of blindness
|
|
JP2002363107A
(ja)
|
2001-06-04 |
2002-12-18 |
Noriyuki Azuma |
色覚不全動物の色覚復元方法
|
|
WO2003012054A2
(en)
|
2001-08-02 |
2003-02-13 |
Institut Clayton De La Recherche |
Methods and compositions relating to improved lentiviral vector production systems
|
|
US20030129203A1
(en)
|
2001-08-27 |
2003-07-10 |
Nautilus Biotech S.A. |
Mutant recombinant adeno-associated viruses
|
|
US7647184B2
(en)
|
2001-08-27 |
2010-01-12 |
Hanall Pharmaceuticals, Co. Ltd |
High throughput directed evolution by rational mutagenesis
|
|
US6723551B2
(en)
|
2001-11-09 |
2004-04-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Production of adeno-associated virus in insect cells
|
|
SG10202108118RA
(en)
|
2001-11-13 |
2021-08-30 |
Univ Pennsylvania |
A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
|
|
ES2467156T3
(es)
|
2001-12-21 |
2014-06-12 |
Medigene Ag |
Una biblioteca de genes estructurales modificados o de partículas modificadas de cápside útiles para la identificación de clones virales con tropismo celular deseado
|
|
AU2003225910A1
(en)
|
2002-03-20 |
2003-10-08 |
Johns Hopkins University |
Raav vector compositions and methods for the treatment of choroidal neovascularization
|
|
US20060292117A1
(en)
|
2002-04-17 |
2006-12-28 |
Loiler Scott A |
Improved rAAv vectors
|
|
AU2003223775A1
(en)
|
2002-04-30 |
2003-11-17 |
Duke University |
Adeno-associated viral vectors and methods for their production from hybrid adenovirus and for their use
|
|
US20040142416A1
(en)
|
2002-04-30 |
2004-07-22 |
Laipis Philip J. |
Treatment for phenylketonuria
|
|
US7254489B2
(en)
|
2002-05-31 |
2007-08-07 |
Microsoft Corporation |
Systems, methods and apparatus for reconstructing phylogentic trees
|
|
US8304233B2
(en)
|
2002-06-04 |
2012-11-06 |
Poetic Genetics, Llc |
Methods of unidirectional, site-specific integration into a genome, compositions and kits for practicing the same
|
|
US7220577B2
(en)
|
2002-08-28 |
2007-05-22 |
University Of Florida Research Foundation, Inc. |
Modified AAV
|
|
GB0220467D0
(en)
|
2002-09-03 |
2002-10-09 |
Oxford Biomedica Ltd |
Composition
|
|
JP2006519026A
(ja)
|
2003-03-04 |
2006-08-24 |
独立行政法人産業技術総合研究所 |
標的物質の細胞導入効率を上昇させるための組成物および方法
|
|
US20070172460A1
(en)
|
2003-03-19 |
2007-07-26 |
Jurgen Kleinschmidt |
Random peptide library displayed on aav vectors
|
|
WO2004108922A2
(en)
|
2003-04-25 |
2004-12-16 |
The Trustees Of The University Of Pennsylvania |
Use of aav comprising a capsid protein from aav7 or aav8 for the delivery of genes encoding apoprotein a or e genes to the liver
|
|
EP1486567A1
(en)
|
2003-06-11 |
2004-12-15 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Improved adeno-associated virus (AAV) vector for gene therapy
|
|
PL2357189T3
(pl)
|
2003-06-19 |
2017-08-31 |
Genzyme Corporation |
Wiriony AAV o zmniejszonej immunoreaktywności i ich zastosowanie
|
|
CA2530582C
(en)
|
2003-06-23 |
2014-09-09 |
A&G Pharmaceutical, Inc. |
Compositions and methods for restoring sensitivity of tumor cells to antitumor therapy and inducing apoptosis
|
|
US9441244B2
(en)
|
2003-06-30 |
2016-09-13 |
The Regents Of The University Of California |
Mutant adeno-associated virus virions and methods of use thereof
|
|
US9233131B2
(en)
|
2003-06-30 |
2016-01-12 |
The Regents Of The University Of California |
Mutant adeno-associated virus virions and methods of use thereof
|
|
US20050148069A1
(en)
|
2003-09-24 |
2005-07-07 |
Gage Fred H. |
IGF-1 instructs multipotent adult CNS neural stem cells to an oligodendroglial lineage
|
|
HUE054805T2
(hu)
|
2003-09-30 |
2021-09-28 |
Univ Pennsylvania |
Adeno-asszociált vírus (AAV) kládok, szekvenciák, az azokat tartalmazó vektorok és alkalmazásaik
|
|
US20060166363A1
(en)
|
2004-01-27 |
2006-07-27 |
Sergei Zolotukhin |
Modified baculovirus expression system for production of pseudotyped rAAV vector
|
|
US7427396B2
(en)
|
2004-06-03 |
2008-09-23 |
Genzyme Corporation |
AAV vectors for gene delivery to the lung
|
|
EP1802334B1
(en)
|
2004-10-21 |
2012-08-29 |
Genentech, Inc. |
Method for treating intraocular neovascular diseases
|
|
CN101090968B
(zh)
|
2004-11-08 |
2011-10-26 |
科罗迈吉尼科斯公司 |
高水平表达蛋白质的宿主细胞的选择
|
|
AU2005316476A1
(en)
|
2004-12-15 |
2006-06-22 |
University Of Florida Research Foundation, Inc. |
Chimeric vectors
|
|
WO2006101634A1
(en)
|
2005-02-17 |
2006-09-28 |
The Regents Of The University Of California |
Müller cell specific gene therapy
|
|
US7922670B2
(en)
|
2005-02-24 |
2011-04-12 |
Warren Jones |
System and method for quantifying and mapping visual salience
|
|
EP3085389A1
(en)
|
2005-04-07 |
2016-10-26 |
The Trustees Of The University Of Pennsylvania |
Method of increasing the function of an aav vector
|
|
US20060234347A1
(en)
|
2005-04-13 |
2006-10-19 |
Harding Thomas C |
Targeting multiple angiogenic pathways for cancer therapy using soluble tyrosine kinase receptors
|
|
AU2006304997B2
(en)
|
2005-10-20 |
2012-03-01 |
Uniqure Ip B.V. |
Improved AAV vectors produced in insect cells
|
|
EP1981548A4
(en)
|
2006-01-20 |
2010-03-24 |
Univ North Carolina |
REINFORCED PRODUCTION OF INFECTIOUS PARVOVIRUS VECTORS IN INSECT CELLS
|
|
US7867484B2
(en)
|
2006-01-27 |
2011-01-11 |
University Of North Carolina At Chapel Hill |
Heparin and heparan sulfate binding chimeric vectors
|
|
US20070190028A1
(en)
|
2006-02-13 |
2007-08-16 |
Jihong Qu |
Method and apparatus for heat or electromagnetic control of gene expression
|
|
US8118752B2
(en)
|
2006-02-16 |
2012-02-21 |
The Board Of Trustees Of The University Of Illinois |
Apparatus and methods for mapping retinal function
|
|
US7384145B2
(en)
|
2006-02-16 |
2008-06-10 |
The Board Of Trustees Of The University Of Illinois |
Mapping retinal function using corneal electrode array
|
|
WO2007120542A2
(en)
|
2006-03-30 |
2007-10-25 |
The Board Of Trustees Of The Leland Stanford Junior University |
Aav capsid library and aav capsid proteins
|
|
US8216575B2
(en)
|
2006-03-31 |
2012-07-10 |
Chengdu Kanghong Biotechnologies Co., Ltd. |
Inhibition of neovascularization with a soluble chimeric protein comprising VEGF FLT-1 and KDR domains
|
|
WO2007128526A2
(en)
|
2006-05-04 |
2007-11-15 |
Fovea Pharmaceuticals Sa |
Combination comprising a vegf inhibitor and a serine protease for treating neovascular diseases
|
|
WO2007131180A2
(en)
|
2006-05-04 |
2007-11-15 |
Wayne State University |
Restoration of visual responses by in vivo delivery of rhodopsin nucleic acids
|
|
JP2009540011A
(ja)
|
2006-06-12 |
2009-11-19 |
エクセジェニックス、インク．ディー／ビー／エー オプコ ヘルス、インク． |
血管新生のｓｉＲＮＡ阻害のための組成物及び方法
|
|
GB0612096D0
(en)
|
2006-06-19 |
2006-07-26 |
Greater Glasgow Nhs Board |
Functional imaging of the retina
|
|
ES2785223T3
(es)
|
2006-06-21 |
2020-10-06 |
Uniqure Ip Bv |
Células de insecto para la producción de vectores de AAV
|
|
JPWO2008001543A1
(ja)
|
2006-06-27 |
2009-11-26 |
株式会社アドバンテスト |
半導体試験装置および半導体メモリの試験方法
|
|
EP2061891B1
(en)
|
2006-08-24 |
2012-04-11 |
Virovek, Inc. |
Expression in insect cells of genes with overlapping open reading frames, methods and compositions therefor
|
|
CN1966082B
(zh)
|
2006-11-03 |
2010-06-30 |
许瑞安 |
一种防治结直肠癌的基因药物及其制备方法和用途
|
|
US8075137B2
(en)
|
2007-02-16 |
2011-12-13 |
Objectivision Limited |
Stimulus method for multifocal visual evoked potential
|
|
US9725485B2
(en)
|
2012-05-15 |
2017-08-08 |
University Of Florida Research Foundation, Inc. |
AAV vectors with high transduction efficiency and uses thereof for gene therapy
|
|
EP2481797A1
(en)
|
2007-04-13 |
2012-08-01 |
Catalyst Biosciences, Inc. |
Modified factor VII polypeptides and uses thereof
|
|
EP1985708B1
(en)
|
2007-04-27 |
2015-04-15 |
Universität Rostock |
Selective targeting of viruses to neural precursor cells
|
|
EP1995309A1
(en)
|
2007-05-21 |
2008-11-26 |
Vivalis |
Recombinant protein production in avian EBx® cells
|
|
US10696983B2
(en)
|
2007-05-30 |
2020-06-30 |
The Trustees Of The University Of Pennsylvania |
Method for transducing cells with primary cilia
|
|
WO2009023805A1
(en)
|
2007-08-16 |
2009-02-19 |
The Research Foundation Of State University Of New York |
Led variable light source
|
|
US8518037B2
(en)
|
2007-10-30 |
2013-08-27 |
Boston Scientific Scimed, Inc. |
Radiofrequency ablation device
|
|
JP2011505147A
(ja)
|
2007-11-30 |
2011-02-24 |
スカラブ ゲノミクス， エルエルシー |
ｌａｃ発現システム
|
|
ES2644880T3
(es)
|
2008-02-19 |
2017-11-30 |
Uniqure Ip B.V. |
Optimización de expresión de proteínas Rep y Cap parvovirales en las células de insecto
|
|
JP2011512417A
(ja)
|
2008-02-20 |
2011-04-21 |
ジェンザイム・コーポレーション |
血管形成の阻害
|
|
WO2009105690A2
(en)
|
2008-02-21 |
2009-08-27 |
Targeted Genetics Corporation |
Devices and methods for delivering polynucleotides into retinal cells of the macula and fovea
|
|
ITFI20080081A1
(it)
|
2008-04-18 |
2009-10-19 |
Strumenti Oftalmici C S O S R |
Procedimento e sistema per la registrazione di risposte elettrofunzionali erg, perg e vep multifocali in tempo reale
|
|
WO2009137006A2
(en)
|
2008-04-30 |
2009-11-12 |
The University Of North Carolina At Chapel Hill |
Directed evolution and in vivo panning of virus vectors
|
|
EP2315833B8
(en)
|
2008-05-20 |
2015-05-27 |
Eos Neuroscience, Inc. |
Vectors for delivery of light-sensitive proteins and methods of use
|
|
ES2330826B1
(es)
|
2008-06-04 |
2010-07-26 |
Proyecto De Biomedicina Cima, S.L. |
Sistema para empaquetamiento de adenovirus de alta capacidad.
|
|
EP2297185A1
(en)
|
2008-06-17 |
2011-03-23 |
Amsterdam Molecular Therapeutics (AMT) B.V. |
Parvoviral capsid with incorporated gly-ala repeat region
|
|
US9192685B2
(en)
|
2008-10-07 |
2015-11-24 |
Bracco Suisse S.A. |
Targeting construct comprising anti-polymer antibody and contrast/therapeutic agents binding to the same
|
|
US8889641B2
(en)
|
2009-02-11 |
2014-11-18 |
The University Of North Carolina At Chapel Hill |
Modified virus vectors and methods of making and using the same
|
|
CN102341406B
(zh)
|
2009-03-04 |
2016-06-08 |
德国癌症研究中心 |
组装活化蛋白（aap）及其用于制备基本上由vp3组成的细小病毒颗粒的应用
|
|
US8679837B2
(en)
|
2009-04-02 |
2014-03-25 |
University Of Florida Research Foundation, Inc. |
Inducible system for highly efficient production of recombinant Adeno-associated virus (rAAV) vectors
|
|
CN101532024A
(zh)
|
2009-04-30 |
2009-09-16 |
许瑞安 |
一种用于基因治疗的新型细胞特异性内含microRNA结合序列的基因HAAVmir
|
|
WO2010138263A2
(en)
|
2009-05-28 |
2010-12-02 |
University Of Massachusetts |
Novel aav 's and uses thereof
|
|
TWI466158B
(zh)
|
2009-07-03 |
2014-12-21 |
Univ Lunghwa Sci & Technology |
電漿測量裝置、電漿系統及測量電漿特性之方法
|
|
EP2287323A1
(en)
|
2009-07-31 |
2011-02-23 |
Association Institut de Myologie |
Widespread gene delivery to the retina using systemic administration of AAV vectors
|
|
EP2292781A1
(en)
|
2009-08-17 |
2011-03-09 |
Genethon |
Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virions
|
|
US20120172419A1
(en)
|
2009-09-15 |
2012-07-05 |
Medical College Of Wisconsin Research Foundation Inc. |
Reagents and methods for modulating cone photoreceptor activity
|
|
US20110270256A1
(en)
|
2009-09-24 |
2011-11-03 |
Medicinelodge, Inc. Dba Imds Co-Innovation |
Surgical rasp with radiofrequency ablation
|
|
ES2683695T3
(es)
|
2010-01-12 |
2018-09-27 |
The University Of North Carolina At Chapel Hill |
Repeticiones terminales invertidas restrictivas para vectores virales
|
|
EP2545165B1
(en)
|
2010-03-11 |
2020-07-29 |
uniQure IP B.V. |
Mutated rep encoding sequences for use in aav production
|
|
WO2011117258A2
(en)
|
2010-03-22 |
2011-09-29 |
Association Institut De Myologie |
Methods of increasing efficiency of vector penetration of target tissue
|
|
KR20130040844A
(ko)
|
2010-03-29 |
2013-04-24 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
약학적으로 유발된 전이유전자 제거 시스템
|
|
WO2011122950A1
(en)
|
2010-04-01 |
2011-10-06 |
Amsterdam Molecular Therapeutics (Amt) Ip B.V. |
Monomeric duplex aav vectors
|
|
EP2563395A4
(en)
|
2010-04-30 |
2013-11-27 |
Lpath Inc |
TREATMENT WITH ANTI-S1P ANTIBODY OF PATIENTS WITH OCULAR DISEASES
|
|
CN201704771U
(zh)
|
2010-04-30 |
2011-01-12 |
陈福环 |
无水箱节水型抽水马桶
|
|
US8663624B2
(en)
|
2010-10-06 |
2014-03-04 |
The Regents Of The University Of California |
Adeno-associated virus virions with variant capsid and methods of use thereof
|
|
US20110052678A1
(en)
|
2010-11-05 |
2011-03-03 |
Shantha Totada R |
Method for treating age related macular degeneration
|
|
DK2640743T3
(en)
|
2010-11-16 |
2017-01-23 |
Excelimmune Inc |
PROCEDURES FOR THE PREPARATION OF RECOMBINANT PROTEINS
|
|
WO2012094560A2
(en)
|
2011-01-07 |
2012-07-12 |
Applied Genetic Technologies Corporation |
Promoters, expression cassettes, vectors, kits, and methods for the treatment of achromatopsia and other diseases
|
|
CN107012171B
(zh)
*
|
2011-04-22 |
2021-07-13 |
加利福尼亚大学董事会 |
具有变异衣壳的腺相关病毒病毒体及其使用方法
|
|
EP3147295B2
(en)
|
2011-08-24 |
2023-11-22 |
The Board of Trustees of the Leland Stanford Junior University |
New avv capsid proteins for nucleic acid transfer
|
|
AU2012327236B2
(en)
|
2011-10-28 |
2016-11-10 |
University Of Florida Research Foundation, Inc. |
Chimeric promoter for cone photoreceptor targeted gene therapy
|
|
WO2013158309A2
(en)
|
2012-04-18 |
2013-10-24 |
The Board Of Trustees Of The Leland Stanford Junior University |
Non-disruptive gene targeting
|
|
EP3470523A1
(en)
|
2012-05-09 |
2019-04-17 |
Oregon Health & Science University |
Adeno associated virus plasmids and vectors
|
|
TWI775096B
(zh)
|
2012-05-15 |
2022-08-21 |
澳大利亞商艾佛蘭屈澳洲私營有限公司 |
使用腺相關病毒(aav)sflt-1治療老年性黃斑部退化(amd)
|
|
WO2013188316A1
(en)
|
2012-06-11 |
2013-12-19 |
Avalanche Biotechnologies, Inc. |
Optical regulation of gene expression in the retina
|
|
EP2940131B1
(en)
|
2012-12-25 |
2019-02-20 |
Takara Bio Inc. |
Aav variant
|
|
CN112779255A
(zh)
|
2013-05-16 |
2021-05-11 |
应用遗传科技公司 |
用于治疗色盲和其它疾病的启动子、表达盒、载体、药盒和方法
|
|
EP3004339B1
(en)
|
2013-05-29 |
2021-07-07 |
Cellectis |
New compact scaffold of cas9 in the type ii crispr system
|
|
CN105247044B
(zh)
|
2013-05-31 |
2021-05-07 |
加利福尼亚大学董事会 |
腺相关病毒变体及其使用方法
|
|
US9597415B2
(en)
*
|
2013-06-28 |
2017-03-21 |
Inserm (Institute National De La Sante Et De La Recherche Medicale) |
Methods for expressing a polynucleotide of interest in the retina of a subject
|
|
US20150025939A1
(en)
|
2013-07-18 |
2015-01-22 |
Somnath Chatterjee |
Company Centric Social Media Platfonn for Content Sharing aud Tracking
|
|
EP3564379A1
(en)
|
2013-09-13 |
2019-11-06 |
California Institute of Technology |
Selective recovery
|
|
AU2014324717B2
(en)
|
2013-09-26 |
2020-10-08 |
University Of Florida Research Foundation, Inc. |
Synthetic combinatorial AAV capsid library for targeted gene therapy
|
|
NZ718926A
(en)
|
2013-10-11 |
2021-12-24 |
Massachusetts Eye & Ear Infirmary |
Methods of predicting ancestral virus sequences and uses thereof
|
|
MX377714B
(es)
|
2013-10-18 |
2025-03-11 |
Regeneron Pharma |
Composiciones que comprenden una combinación de un antagonista de vegf y un anticuerpo anti-ctla-a.
|
|
ES2768763T3
(es)
|
2014-03-04 |
2020-06-23 |
Univ Florida |
Vectores rAAV mejorados y métodos para la transducción de fotorreceptores y células EPR
|
|
EP3800191B1
(en)
*
|
2014-03-17 |
2025-08-20 |
Adverum Biotechnologies, Inc. |
Compositions and methods for enhanced gene expression in cone cells
|
|
EP3137497B2
(en)
|
2014-05-02 |
2025-03-05 |
Genzyme Corporation |
Aav vectors for retinal and cns gene therapy
|
|
WO2015191693A2
(en)
|
2014-06-10 |
2015-12-17 |
Massachusetts Institute Of Technology |
Method for gene editing
|
|
JP7095994B2
(ja)
|
2015-03-02 |
2022-07-05 |
アドヴェラム バイオテクノロジーズ， インコーポレイテッド |
ポリヌクレオチドを網膜錐体に硝子体内送達するための組成物及び方法
|
|
PT3265568T
(pt)
|
2015-03-06 |
2020-08-20 |
Massachusetts Eye & Ear Infirmary |
Terapias de aumento de genes para a degeneração hereditária da retina causada por mutações no gene prpf31
|
|
US20190000940A1
(en)
|
2015-07-31 |
2019-01-03 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of aadc deficiency
|
|
GB2545763A
(en)
|
2015-12-23 |
2017-06-28 |
Adverum Biotechnologies Inc |
Mutant viral capsid libraries and related systems and methods
|
|
US20190142975A1
(en)
|
2016-04-29 |
2019-05-16 |
Adverum Biotechnologies, Inc. |
Evasion of neutralizing antibodies by a recombinant adeno-associated virus
|
|
WO2017197355A2
(en)
|
2016-05-13 |
2017-11-16 |
4D Molecular Therapeutics Inc. |
Adeno-associated virus variant capsids and methods of use thereof
|
|
DK3472317T3
(da)
|
2016-06-16 |
2022-05-23 |
Adverum Biotechnologies Inc |
Sammensætninger og fremgangsmåder til reduktion af okulær vaskularisation
|
|
SI3471780T1
(sl)
|
2016-06-16 |
2021-03-31 |
Adverum Biotechnologies, Inc. |
Zdravljenje SDM-ja z uporabo različice AAV2 z afliberceptom
|
|
CA3040179A1
(en)
|
2016-10-19 |
2018-04-26 |
Adverum Biotechnologies, Inc. |
Modified aav capsids and uses thereof
|
|
CN110650733A
(zh)
|
2017-02-28 |
2020-01-03 |
阿德夫拉姆生物技术股份有限公司 |
经过修饰的aav衣壳和其用途
|
|
EP4653536A3
(en)
|
2017-03-17 |
2026-02-25 |
Adverum Biotechnologies, Inc. |
Compositions and methods for enhanced gene expression
|